BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 17116731)

  • 21. JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins.
    Li X; Stankovic M; Lee BP; Aurrand-Lions M; Hahn CN; Lu Y; Imhof BA; Vadas MA; Gamble JR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1200-6. PubMed ID: 19461049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neddylated Cullin 3 is required for vascular endothelial-cadherin-mediated endothelial barrier function.
    Sakaue T; Fujisaki A; Nakayama H; Maekawa M; Hiyoshi H; Kubota E; Joh T; Izutani H; Higashiyama S
    Cancer Sci; 2017 Feb; 108(2):208-215. PubMed ID: 27987332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-1 regulates microvascular reactivity and protects the microcirculation during acute endothelial dysfunction: role of eNOS and VE-cadherin.
    Alfieri A; Ong AC; Kammerer RA; Solanky T; Bate S; Tasab M; Brown NJ; Brookes ZL
    Pharmacol Res; 2014 Feb; 80():43-51. PubMed ID: 24407281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VE-cadherin in vascular development: a coordinator of cell signaling and tissue morphogenesis.
    Lagendijk AK; Hogan BM
    Curr Top Dev Biol; 2015; 112():325-52. PubMed ID: 25733145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability.
    Dejana E; Lampugnani MG; Martinez-Estrada O; Bazzoni G
    Int J Dev Biol; 2000; 44(6):743-8. PubMed ID: 11061439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
    Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
    Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.
    Fukuhara S; Sakurai A; Sano H; Yamagishi A; Somekawa S; Takakura N; Saito Y; Kangawa K; Mochizuki N
    Mol Cell Biol; 2005 Jan; 25(1):136-46. PubMed ID: 15601837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rap1 Small GTPase Regulates Vascular Endothelial-Cadherin-Mediated Endothelial Cell-Cell Junctions and Vascular Permeability.
    Yamamoto K; Takagi Y; Ando K; Fukuhara S
    Biol Pharm Bull; 2021; 44(10):1371-1379. PubMed ID: 34602545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration of human hematopoietic progenitor cells across bone marrow endothelium is regulated by vascular endothelial cadherin.
    van Buul JD; Voermans C; van den Berg V; Anthony EC; Mul FP; van Wetering S; van der Schoot CE; Hordijk PL
    J Immunol; 2002 Jan; 168(2):588-96. PubMed ID: 11777950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of VE-cadherin in vascular morphogenesis and permeability control.
    Dejana E; Vestweber D
    Prog Mol Biol Transl Sci; 2013; 116():119-44. PubMed ID: 23481193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo.
    Broermann A; Winderlich M; Block H; Frye M; Rossaint J; Zarbock A; Cagna G; Linnepe R; Schulte D; Nottebaum AF; Vestweber D
    J Exp Med; 2011 Nov; 208(12):2393-401. PubMed ID: 22025303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial-specific deficiency of Junctional Adhesion Molecule-C promotes vessel normalisation in proliferative retinopathy.
    Economopoulou M; Avramovic N; Klotzsche-von Ameln A; Korovina I; Sprott D; Samus M; Gercken B; Troullinaki M; Grossklaus S; Funk RH; Li X; Imhof BA; Orlova VV; Chavakis T
    Thromb Haemost; 2015 Nov; 114(6):1241-9. PubMed ID: 26311310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rap1 small GTPase is essential for maintaining pulmonary endothelial barrier function in mice.
    Yamamoto K; Watanabe-Takano H; Oguri-Nakamura E; Matsuno H; Horikami D; Ishii T; Ohashi R; Kubota Y; Nishiyama K; Murata T; Mochizuki N; Fukuhara S
    FASEB J; 2023 Dec; 37(12):e23310. PubMed ID: 38010922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.
    Shaw SK; Perkins BN; Lim YC; Liu Y; Nusrat A; Schnell FJ; Parkos CA; Luscinskas FW
    Am J Pathol; 2001 Dec; 159(6):2281-91. PubMed ID: 11733377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-induced vascular permeability is mediated by FAK.
    Chen XL; Nam JO; Jean C; Lawson C; Walsh CT; Goka E; Lim ST; Tomar A; Tancioni I; Uryu S; Guan JL; Acevedo LM; Weis SM; Cheresh DA; Schlaepfer DD
    Dev Cell; 2012 Jan; 22(1):146-57. PubMed ID: 22264731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.
    Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J
    PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
    Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
    Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.